Zhejiang Wecome Pharmaceutical Company Limited

SZSE:300878.SZ

23.26 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -10.14324.335-77.3894.7337.09527.526-49.48736.94534.06622.923.77728.94743.49820.27346.51831.25342.31315.73242.47226.57528.48328.483
Depreciation & Amortization 14.76414.76447.026-24.10612.58412.58413.85313.8539.2039.20310.57610.5764.3784.37812.169-6.146.14011.89000
Deferred Income Tax 0000000000000000000000
Stock Based Compensation 0000000000000000000000
Change In Working Capital -43.555029.9316.423-6.423035.02435.861-35.8610-197.291160.698-160.6980-144.27476.516-76.5160-40.554000
Accounts Receivables -62.531067.534-14.56514.565038.15253.429-53.4290-151.672147.787-147.7870-122.42873.19-73.190-53.363000
Change In Inventory 18.9760-37.60320.988-20.9880-3.127-17.56917.5690-45.61912.91-12.910-21.8473.326-3.326012.809000
Change In Accounts Payables 0000000000000000000000
Other Working Capital 0000000000000000000000
Other Non Cash Items 28.217-40.77431.74-7.989-8.817-26.62388.087-57.73223.895-14.85719.482-37.005-55.911-60.899134.181-113.54835.682-17.21425.8171.773-6.089-6.089
Operating Cash Flow 3.31-16.43931.307-20.94334.43913.48787.47828.92731.302-1.13912.683-18.634-16.79-45.00448.594-11.9197.618-1.48139.62528.34922.39422.394
Investing Activities:
Investments In Property Plant And Equipment -25.179-37.408-16.29-31.678-41.74-49.578-64.887-66.107-40.971-76.478-33.733-60.717-27.418-49.229-75.137-31.527-32.955-12.72-31.782-24.612-29.291-29.291
Acquisitions Net -1.85603.01100.0120-9.5520.0130.0720-12.8410.170000000000
Purchases Of Investments 60-60-242.770-2.2170-15.028-1.838-0.072-8.13532.007-34.9130000000000
Sales Maturities Of Investments 23110250.02702.20502.0846.6146.6146.614-14140000000000
Other Investing Activites -233.41241380.694-241252.244-0.581-182.83600.072-1.52-32.517-20.743-27.418-49.229-19.95800.023-12.7200-3-3
Investing Cash Flow 30.554153.561121.646-272.678210.505-50.159-270.219-61.318-34.284-77.999-34.243-81.46-27.418-49.229-95.095-31.527-32.932-12.72-31.782-24.612-32.291-32.291
Financing Activities:
Debt Repayment -159.26-239.838-2.682-180-16.519-88.24-1-20000-500-14.7-137.3790-15.3-28.5-58.588-13.48100
Common Stock Issued 0000000000000000000000
Common Stock Repurchased -49.9980-30000000-3000-68.9140000000
Dividends Paid -39.395-1.292-2.993-1.718-0.92-1.385-43.437-0.481-42.086-0.5-5.1450-75.755-0.086-1.253-2.421-2.431-1.729-1.776-1.359-1.296-1.296
Other Financing Activities -39.395-1.292-14.999230.997-0.92176.48150.003145.47950-0.5-11.277503-0.086-37.583730.17424.07141.24657.588-15.01925.18925.189
Financing Cash Flow 62.666-241.13-21.12449.279-17.43886.85546.329124.9987.914-0.5-16.42250-72.755-14.786-176.215727.7536.3411.01755.812-16.37823.89423.894
Other Information:
Effect Of Forex Changes On Cash 000-000105.333-103.254.5310000000000000
Net Change In Cash 94.403-104.009131.828-244.342227.50650.183-31.079-10.6429.463-86.252-37.982-50.094-116.963-109.019-223.015684.307-18.674-3.18563.654-12.64213.99713.997
Cash At End Of Period 320.582225.921326.582194.754439.096211.591161.408192.487203.129193.666279.919317.9367.994484.957593.976816.991132.684151.358154.54390.889103.53113.997